Form CORRESP - Correspondence:
SEC Accession No. 0001193125-24-167034
Filing Date
2024-06-24
Accepted
2024-06-24 17:06:27
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 6038
  Complete submission text file 0001193125-24-167034.txt   7003
Mailing Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339
Business Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339 678-392-3419
Inhibikase Therapeutics, Inc. (Filer) CIK: 0001750149 (see all company filings)

EIN.: 263407249 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)